Radiosensitization of NSCLC cells to X-rays and carbon ions by the CHK1/CHK2 inhibitor AZD7762, Honokiol and Tunicamycin

Radiat Environ Biophys. 2020 Nov;59(4):723-732. doi: 10.1007/s00411-020-00867-6. Epub 2020 Aug 28.

Abstract

Although radiotherapy, especially carbon-ion radiotherapy, is an effective treatment modality against non-small-cell lung cancer (NSCLC), studies using radiation combined with sensitizer for improving the efficacy of radiotherapy are still needed. In this work, we aimed to investigate in NSCLC A549 and H1299 cell lines the effects of different linear energy transfer (LET) radiations combined with diverse sensitizing compounds. Cells pretreated with the CHK1/CHK2 inhibitor AZD7762, Honokiol or Tunicamycin were irradiated with low-LET X-rays and high-LET carbon ions. Cell survival was assessed using the clonogenic cell survival assay. Cell cycle distribution and apoptosis were measured with flow cytometry, and DNA double strand break (DSB) and repair were detected using γ-H2AX immunofluorescence staining. Our results revealed that AZD7762, Honokiol and Tunicamycin demonstrated low cytotoxicity to NSCLC cells and a pronounced radiosensitizing effect on NSCLC cells exposed to carbon ions than X-rays. Unrepaired DNA DSB damages, the abrogation of G2/M arrest induced by irradiation, and finally apoptotic cell death were the main causes of the radiosensitizing effect. Thus, our data suggest that high-LET carbon ion combined with these compounds may be a potentially effective therapeutic strategy for locally advanced NSCLC.

Keywords: AZD7762; Carbon ions; Honokiol; Radiosensitivity; Tunicamycin; X-rays.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Apoptosis / radiation effects
  • Biphenyl Compounds / pharmacology*
  • Carbon
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Carcinoma, Non-Small-Cell Lung / radiotherapy
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Cell Proliferation / radiation effects
  • Checkpoint Kinase 1 / antagonists & inhibitors*
  • Checkpoint Kinase 2 / antagonists & inhibitors*
  • DNA Breaks, Double-Stranded
  • G2 Phase Cell Cycle Checkpoints / drug effects
  • G2 Phase Cell Cycle Checkpoints / radiation effects
  • Humans
  • Ions
  • Lignans / pharmacology*
  • Linear Energy Transfer
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / radiotherapy
  • Protein Kinase Inhibitors / pharmacology*
  • Radiation Tolerance / drug effects
  • Radiation-Sensitizing Agents / pharmacology*
  • Thiophenes / pharmacology*
  • Tunicamycin / pharmacology*
  • Urea / analogs & derivatives*
  • Urea / pharmacology
  • X-Rays

Substances

  • 3-(carbamoylamino)-5-(3-fluorophenyl)-N-(3-piperidyl)thiophene-2-carboxamide
  • Antineoplastic Agents
  • Biphenyl Compounds
  • Ions
  • Lignans
  • Protein Kinase Inhibitors
  • Radiation-Sensitizing Agents
  • Thiophenes
  • Tunicamycin
  • honokiol
  • Carbon
  • Urea
  • Checkpoint Kinase 2
  • CHEK1 protein, human
  • CHEK2 protein, human
  • Checkpoint Kinase 1